Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 1,172,918 shares at $11.18 ($13.3M) on 2025-05-07, disclosed to the SEC on 2025-05-08.
Open-market sale of $13.3M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.47 | 273,959 | $3.1M | 23.7% |
| 2 | $11.47 | 273,959 | $3.1M | 23.7% |
| 3 | $11.18 | 625,000 | $7.0M | 52.6% |
| Total | $11.32 avg | 1,172,918 | $13.3M | 100% |
| Filing → |
| ROIV | SELL | 2025-09-05 | $30.0M | — | Filing → |
| ROIV | SELL | 2025-06-23 | $26.2M | — | Filing → |
| ROIV | SELL | 2025-06-06 | $14.7M | — | Filing → |